N-(5-芳苄叉基饶丹宁)左氧氟沙星酰胺的合成及抗肿瘤活性

doi:10.11944/j.issn.1000-0518.2019.08.180409

摘要/Abstract

摘要：

为进一步发现氟喹诺酮药物向抗肿瘤活性转化的结构修饰新策略,用酰氨基为左氧氟沙星(1)C-3羧基的电子等排体,5-芳苄叉基饶丹宁为其功能修饰基,设计合成了N-(5-芳苄叉基饶丹宁)左氧氟沙星酰胺类目标化合物(6a-6n)。体外抗肿瘤活性结果表明,所合成的14个化合物的活性均强于母体左氧氟沙星,且对正常细胞表现出较低的细胞毒性作用。构效关系表明,增大芳基取代基的体积或供电性均导致抗肿瘤活性的明显降低,反之,吸电子取代苯基或芳香杂环类目标化合物的抗肿瘤活性强于其他取代基类。其中,硝基化合物6l、呋喃6m和吡啶6n对人胰腺癌细胞株(Capan-1)的半数抑制浓度(IC₅₀) 与对照抗肿瘤药阿霉素(1.6 μmol/L)相当,分别为1.8、0.8和1.3 μmol/L。因此,芳苄叉基饶丹宁修饰的酰氨基替代C-3羧基有利于提高氟喹诺酮的抗肿瘤活性。

关键词: 氟喹诺酮, 酰胺, 饶丹宁, α,β-不饱和酮, 电子等排体, 抗肿瘤活性

Abstract:

To develope an efficiently structural modification strategy for transforming antibacterial fluoroquinolone into antitumor agent, novel N-arylidene arylidene rhodanine levofloxacin amide derivatives(6a-6n) were synthesized via amide modification with functionalized arylidene rhodanine scaffold as the bioisostere of the C-3 carboxylic group. The in vitro antitumor assay indicated that the title compounds exhibited more significant potency against three test cancer cell lines than levofloxacin, but with lower cytotoxicity against the normal cells than doxorubicin as a comparison. The SAR(structure-activity relationship) reveals that the increase in the bulky or electron-donating substituents bearing phenyl ring obviously reduces the antitumor activity. Conversely, compounds with electron-withdrawing nitro- or fluorophenyl or heteroaromatic rings such as furan or pyridine ring display comparable activity to doxorubicin. Thus, an amide group modified by arylidene rhodanine scaffold as an isostere of the C-3 carboxylic acid group appears to an alternative route for further design of antitumor fluoroquinolone.

Key words: fluoroquinolone, amide, rhodanine, α,β-unsaturated ketone, bioisostere, antitumor activity

张会丽, 李珂, 黄文龙, 王蕊, 胡国强. N-(5-芳苄叉基饶丹宁)左氧氟沙星酰胺的合成及抗肿瘤活性[J]. 应用化学, 2019, 36(8): 897-903.

ZHANG Huili, LI Ke, HUANG Wenlong, WANG Rui, HU Guoqiang. Synthesis and Antitumor Activity of N-Arylidene-Rhodanine Levofloxacin Amides[J]. Chinese Journal of Applied Chemistry, 2019, 36(8): 897-903.

参考文献

[1]	Mendgen T,Steuer C,Klein C D.Privileged Scaffolds or Promiscuous Binders:A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry[J]. J Med Chem,2012,55(2):743-753.
[2]	Xiang Y,Chen C,Wang W M, et al. Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors[J]. ACS Med Chem Lett,2018,9(4):359-364.
[3]	Slepikas L,Chiriano G,Perozzo R, et al. In Silico Driven Design and Synthesis of Rhodanine Derivatives as Novel Antibacterials Targeting the Enoyl Reductase InhA[J]. J Med Chem,2016,59(24):10917-10928.
[4]	Zdrazil B,Guha R.The Rise and Fall of a Scaffold:A Trend Analysis of Scaffolds in the Medicinal Chemistry Literature[J]. J Med Chem,2018,61(11):4688-4703.
[5]	Jackson P A,Widen J C,Harki D A, et al. Covalent Modifiers:A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions[J]. J Med Chem,2017,60(3):839-885.
[6]	Bisacchi G S,Hale M R.A “Double-Edged” Scaffold:Antitumor Power Within the Antibacterial Quinolone[J]. Curr Med Chem,2016,23(6):520-577.
[7]	XIE Yusuo,GAO Liuzhou,YAN Qiang, et al. Synthesis and Antitumor Activity of Fluoroquinolon-3-yl s-Triazole Sulfide-Ketone Thiosemicarbazone Derivatives of Ofloxacin[J]. Chinese J Appl Chem,2016,33(1):25-31(in Chinese). 谢玉锁,高留州,闫强,等. 氟喹诺酮C-3均三唑硫醚酮缩氨基硫脲衍生物的合成及抗肿瘤活性[J]. 应用化学,2016,33(1):25-31.
[8]	LI Yuanyuan,ZHANG Chenxia,HUANG Wenlong, et al. Synthesis and Antitumor Activity of C-3 Thiazolotriazole Unsaturated Ketone Derivatives from Levofloxacoin[J]. Chinese J Appl Chem,2019,36(6):671-676(in Chinese). 李元元,张呈霞,黄文龙,等. 左氧氟沙星的噻唑并均三唑衍生物的合成及抗肿瘤活性[J]. 应用化学,2019,36(6):671-676.
[9]	Hu G Q,Wang G Q,Duan N N, et al. Design, Synthesis and Antitumor Activity of Fluoroquinolone C3 Heterocyclic Bis-oxadiazole Methylsulfide Derivatives Derived from Levofloxacin[J]. Chem Res Chinese Univ,2012,28(6):980-984.
[10]	GAO Liuzhou.Synthesis and Anti-proliferative Activity of Fluoroquinolone C3(Rhodanine Unsaturated Ketone) Amine Derivatives[D]. Kaifeng:School of Pharmacy, Henan University,2015(in Chnese). 高留州. 氟喹诺酮C-3(饶丹宁不饱和酮)酰胺类衍生物的合成与抗肿瘤活性研究[D]. 开封:河南大学药学院,2015.

[1]	陈飞越, 苏振宁, 程全中, 谭博仁, 李智永, 俞小花, 王勇. 氯仿萃取分离N，N-二甲基甲酰胺工艺[J]. 应用化学, 2023, 40(4): 554-561.
[2]	杨弘力, 王倩琪, 汪欢, 颜晗, 林芃晖, 宋金秋, 丁洋, 李善花, 李福男. 肉桂酰胺类化合物的结构优化、合成及其抗肝癌活性[J]. 应用化学, 2023, 40(2): 261-267.
[3]	成燕琴, 黎卓熹, 王有娣, 徐娟娟, 卞证. 结构简单的4-羟基脯氨酰胺高效催化醛和硝基烯不对称迈克尔加成反应[J]. 应用化学, 2023, 40(1): 146-154.
[4]	陈丽燕, 谈东兴, 韩福社. 三［（S）-α，α-二（4-甲基苯基）-2-吡咯烷甲醇］膦酰胺催化链状酮酯化合物的不对称还原反应[J]. 应用化学, 2022, 39(3): 425-438.
[5]	张会丽, 崔红艳, 黄文龙, 胡国强. 饶丹宁甲叉基取代左氧氟沙星衍生物的合成与抗肿瘤活性[J]. 应用化学, 2021, 38(2): 188-194.
[6]	张红彦, 杨孟芝, 姜春勇, 蔡小华. 醋酸铜催化硝基芳烃的还原甲酰化:一种简便价廉的甲酰胺合成策略[J]. 应用化学, 2021, 38(12): 1632-1638.
[7]	张会丽, 崔红艳, 黄文龙, 胡国强. 左氧氟沙星3-芳苄叉基-喹啉-4-酮衍生物的合成及抗肿瘤活性[J]. 应用化学, 2020, 37(12): 1426-1431.
[8]	胡学一, 罗敏敏, 方云, 李俊国, 孙洋, 李华山. 乙醇胺类原料形成亚硝胺的比较[J]. 应用化学, 2019, 36(9): 1061-1068.
[9]	胡学一, 罗敏敏, 方云, 李俊国, 孙洋, 李华山. 乙醇胺类原料形成亚硝胺的比较[J]. 应用化学, 2019, 36(9): 0-.
[10]	李元元,张呈霞,黄文龙,陈超然,胡国强. 左氧氟沙星的噻唑并均三唑衍生物的合成及抗肿瘤活性[J]. 应用化学, 2019, 36(6): 671-676.
[11]	王琦, 仝玉章, 贾晓普, 杨春, 王庆伦, 廖代正. 基于N,N'-双(3-吡啶基)-对苯二甲酰胺和1,3,5-苯三甲酸的二维Co(Ⅱ)金属有机骨架的合成、结构和磁性[J]. 应用化学, 2019, 36(12): 1397-1405.
[12]	马园园, 刘晗婷, 彭利, 马敬红, 龚静华. 微流控纺丝制备葡萄糖响应凝胶纤维[J]. 应用化学, 2018, 35(10): 1208-1214.
[13]	段元首, 贾凤霞, 王朔, 李丽芳. 聚N-异丙基丙烯酰胺/类水滑石复合水凝胶的制备及温敏性[J]. 应用化学, 2018, 35(1): 102-108.
[14]	尚吉光, 孙国新. 氯化铝中萃取铁工艺[J]. 应用化学, 2018, 35(1): 75-81.
[15]	丁红霞, 武英, 刘正平. 阳离子型可聚合咪唑类离子液体-丙烯酰胺共聚物的制备及其对盐酸腐蚀碳钢缓蚀行为[J]. 应用化学, 2017, 34(8): 0-0.